Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics of Etoposide in Patients With Breast Cancer Receiving High-Dose Etoposide

NCT00026949 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00026949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00026949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics of Etoposide in Patients With Breast Cancer Receiving High-Dose Etoposide
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Completed
Start date
August 31, 1999
Completion date
August 31, 2004
Enrollment
33
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer